CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Methodological consensus on clinical proton MRS of the brain: Review and recommendations
Authors
Ovidiu Andronesi
Peter B. Barker
+30 more
Robert Bartha
Alberto Bizzi
Patrick J. Bolan
Kevin M. Brindle
In Young Choi
Cristina Cudalbu
Ulrike Dydak
Uzay E. Emir
Ramon G. Gonzalez
Stephan Gruber
Rolf Gruetter
Rakesh K. Gupta
Arend Heerschap
Anke Henning
Hoby P. Hetherington
Petra S. Huppi
Ralph E. Hurd
Kejal Kantarci
Risto A. Kauppinen
Dennis W.J. Klomp
Roland Kreis
Marijn J. Kruiskamp
Martin O. Leach
Alexander P. Lin
Peter R. Luijten
Małgorzata Marjańska
Andrew A. Maudsley
Dieter J. Meyerhoff
Carolyn E. Mountford
Martin Wilson
Publication date
1 August 2019
Publisher
Scholarship@Western
Abstract
© 2019 International Society for Magnetic Resonance in Medicine Proton MRS (1H MRS) provides noninvasive, quantitative metabolite profiles of tissue and has been shown to aid the clinical management of several brain diseases. Although most modern clinical MR scanners support MRS capabilities, routine use is largely restricted to specialized centers with good access to MR research support. Widespread adoption has been slow for several reasons, and technical challenges toward obtaining reliable good-quality results have been identified as a contributing factor. Considerable progress has been made by the research community to address many of these challenges, and in this paper a consensus is presented on deficiencies in widely available MRS methodology and validated improvements that are currently in routine use at several clinical research institutions. In particular, the localization error for the PRESS localization sequence was found to be unacceptably high at 3 T, and use of the semi-adiabatic localization by adiabatic selective refocusing sequence is a recommended solution. Incorporation of simulated metabolite basis sets into analysis routines is recommended for reliably capturing the full spectral detail available from short TE acquisitions. In addition, the importance of achieving a highly homogenous static magnetic field (B0) in the acquisition region is emphasized, and the limitations of current methods and hardware are discussed. Most recommendations require only software improvements, greatly enhancing the capabilities of clinical MRS on existing hardware. Implementation of these recommendations should strengthen current clinical applications and advance progress toward developing and validating new MRS biomarkers for clinical use
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Scholarship@Western
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ir.lib.uwo.ca:biophysicspu...
Last time updated on 20/03/2021